搜索新闻
按年份查询
媒体联系

电子邮箱:id201@e-techco.com

联系电话:86-755-83209797

易特科首席科学家Edvard Moser(诺贝尔医学奖得主)会见深圳副市长高自民

日期:2018-04-13 来源:易特科 浏览次数15244

      2018年4月12日,受深圳市委书记王伟中、市长陈如桂的委托,深圳市副市长高自民会见了易特科集团首席科学家、2014年诺贝尔医学奖得主Edvard Moser 教授以及董事长兼CEO张贯京先生一行,听取了易特科集团以及坪山区政府关于共建智慧医疗诺奖实验室的项目进展汇报,表示充分支持和高度关注,并做出了重要指示。坪山区区委副书记、区长陶永欣、深圳市科创委主任梁永生、深圳市卫计委副主任刘堃、深圳市外办副主任孙怀忠也参加了会见。

     高自民表示,深圳一直致力于推动科学技术的基础研究与应用研究,鼓励企业、研究机构和高校开展与世界前沿科学家团队的合作。他希望莫索尔教授与易特科集团的创新团队在深圳开展具体务实的研究及成果转化项目,借助坪山的诺奖实验室项目,助力深圳生物科技与生命健康产业引领全球发展趋势。

     Edvard Moser 教授则表示,他希望通过其脑科学研究方面的成果,与在深的创新团队开展生物医疗领域的跨界合作,为人类健康事业创造更多福祉。他表示,他的大量工作是通过研究正常大脑的运行机制来探索与阿尔兹海默类似病症的发病机理,并期望找到阿尔兹海默病的早期生物标志物和早期分子诊断原理。这次与易特科集团(前海安测)携手合作,在坪山区共建智慧医疗诺奖实验室,他的团队从事大脑研究已有二十多年,而(易特科集团)前海安测在疾病监测方面颇有经验、研究成果卓著,且拥有全球第四中国第一的智慧医疗专利,双方各取所长,相信一定会在大脑定位和记忆疾病方面,例如阿尔兹海默病,取得突破性进展,为中国的大健康产业和公共卫生,为人类战胜目前最为严峻的脑神经紊乱疾病做出贡献。

      前海安测爱德华诺奖实验室,以常见阿尔茨海默病为起点,致力于神经科学相关研究及产业化应用,本项目建成后,将形成AD检测服务、健康管理、预防与干预、VR病理呈现与追踪、记忆增强器等产品与服务,开发个性化的数据库并对接安测慢病健康管理平台,并在易特科(前海安测)公司全国范围内合作的650多家医卫机构进行择优应用示范,带动深圳市和坪山区在“智慧医疗+智慧健康+智慧养老+AI” 领域走在全国前列。

      易特科集团(深圳市易特科信息技术有限公司)注册资本10亿元人民币,深圳市前海安测信息技术有限公司是集团拟IPO的平台,注册资本2亿元人民币,是一家拥有15年专业研发和服务背景,专注于生命IT的高新技术企业,是国内外领先的生物传感器、生命搜索与定位技术、医疗信息化、健康管理、慢病干预、中医治未病的技术提供商。集团总部设在深圳南山数字技术园,在广州、北京、天津、西安、石家庄、福州、上海、桂林、香港等地设有分支机构,在北爱尔兰、美国硅谷、加拿大多伦多等地设有海外研究院。拥有和运营的健康管理中心近90家,客户遍布全国20多个省市650多家三甲医院、二甲医院和各级医卫机构,全国市场全面铺开,智能自助监测一体机、互联网+慢病管理、互联网+急救、互联网+中医、云HIS等医疗信息化产品得到了市场客户广泛好评,业务拓展到加拿大、美国、欧洲等国家和地区。2017年,易特科集团全年营收总额突破16亿元人民币。

      近年来,易特科(前海安测)通过与国内外知名高校、研究所等机构合作,引进国内外顶尖级别的人才团队,在人工智能及智慧医疗领域进行持续的创新探索和产业化应用。自主研发的中医四诊仪、体质辨识仪、治未病服务系统等产品和服务,是利用人工智能技术结合传统中医药理论和信息技术,在中医领域的应用,为提高中医的数字化、信息化、智能化水平做出了重大创新突破,这得到了国家中医药管理局、中国中医科学院、中华中医药学会等诸多领导和专家的充分认可。此外,易特科集团研发团队还将人工智能与医疗信息化紧密结合,采用条件随机场(CRF)、循环神经网络(RNN)、卷积神经网络(CNN)等深度学习算法,解决了自然语言处理(NLP)之中的命名实体识别、实体修饰、文本分类等问题,构建出医学知识图谱,并结合相关决策算法和模型应用于临床数据中心(CDR)、电子病历系统(EMR)、临床信息系统(CIS)、健康体检管理系统(PEIS),实现了临床辅助决策(CDSS)、病历检索与分析(CP)、医学数据挖掘与应用(DATA MINING)等,这样的创新应用在全国,乃至全世界都处于领先突破地位。

     On April 12, 2018, commissioned by Secretary of Shenzhen Party Committee Wang Weizhong and Mayor Chen Rugui, Shenzhen Vice Mayor Gao Zimin met with E-Techco Group Chief Scientist, 2014 Nobel Prize-winning Professor Edvard Moser and Chairman and CEO. Mr. Zhang Guanjing and his teams listened to the E-Techco Group and the Pingshan District Government's report on the progress of the project to jointly build the Smart Healthcare Nobel Prize Laboratory. They expressed their full support and attention and made important instructions. Tao Yongxin, head of Pingshan District, Liang Yongsheng, director of the Shenzhen Branch, and Liu Yong, deputy director of the Shenzhen Municipal Health and Development Commission, and Sun Huaizhong, deputy director of the Shenzhen Foreign Affairs Office also attended the meeting.

     Vice Mayor Gao Zimin stated that Shenzhen has always been committed to promoting basic research and applied research in science and technology, and encouraging companies, research institutes, and universities to cooperate with the world's leading scientists. He hopes that the Moser innovation team will carry out concrete and pragmatic research and achievement transformation projects in Shenzhen to help Shenzhen's biotechnology and life and health industries lead the global development trend.

     Prof. Edvard Moser stated that he hopes to create more benefits for human health through cross-border cooperation in the field of biomedicine with deep innovation teams through his achievements in brain science research. He said that much of his work is to explore the pathogenesis of similar disorders with Alzheimer's by studying the normal brain's operating mechanism, and hope to find early biomarkers and early molecular diagnostic principles of Alzheimer's disease. This time, we cooperated with Qianhai AnyCheck and built a smart medical Nobel laboratory. His team has been engaged in brain research for more than 20 years. Qianhai AnyCheck has experienced in disease monitoring and has achieved outstanding research results. The director believes that he will definitely make breakthroughs in brain localization and memory diseases, such as Alzheimer's disease, and contribute to China's great health industry and public health, and for humanity to overcome the most severe brain disorder.

     Qianhai AnyCheck Edvard Nobel Prize Lab is based on common Alzheimer's disease and is dedicated to neuroscience-related research and industrial applications. After the project is completed, it will form AD testing services, health management, prevention and intervention, and VR pathology. Presentation and tracking, memory enhancer and other products and services, development of personalized database and connection and safety of chronic disease health management platform, and in our countrywide cooperation of more than 650 medical institutions to select the best application demonstration, driving the city We are at the forefront of the nation in the field of “Smart Medical + Smart Health + Smart Pension + AI”.

     E-Techco group (Shenzhen E-Techco Information Technology Co., Ltd.) registered capital of 1 billion yuan. And E-Techco Group (Qianhai AnyCheck) is a High-Tech enterprise with 15 years R&D and service background, which focuses on Internet & medical & health & geriatric service, and it is in the domestic and overseas leading level of biosensor, life searching and positioning, medical informatization, health management, chronic diseases prevention, TCM preventive medicine technology provider and service practitioner. The company HQ is located in Shenzhen, with branches based in Guangzhou, Beijing, Tianjin, Xian, Shijiazhuang, Fuzhou, Shanghai, Hong Kong, with overseas institutes in north Ireland, American Silicon Valley, Toronto and so on. The number of health management centers owned and operated by E-Techco increased to nearly 90. It has more than 650 grade-2&class-A hospitals, grade 3&class 1 hospitals, and all levels health and medical institutions. The national market have been fully opened, intelligent self-help integrated machine, internet & chronic disease management, internet & emergency, internet & TCM, cloud HIS and other medical informatization products have been widely acclaimed by customers. Its business expanded to Canada, America, EU and other countries and regions. In 2017, the total annual revenue of etek group exceeded 1.6 billion RMB.

     In recent years, through cooperation with famous universities and research institutes at home and abroad, E-Techco (Qianhai AnyCheck) introduced the top level talent teams at home and abroad, and continued to carry out continuous innovative exploration and industrial application in the field of artificial intelligence and intelligent medical treatment. Independent research and development of TCM Constitution identification instrument, disease prevention and service system of products and services, is a combination of traditional Chinese medicine theory and information technology with artificial intelligence technology, the application in the field of Chinese medicine, Chinese medicine to improve the digital information and intelligent level has made a major breakthrough innovation, which has been fully recognized by the State Administration of traditional Chinese medicine, China Academy of traditional Chinese medicine, Chinese Medicine Institute and many other leaders and experts. In addition, E-techco Group R & D team will artificial intelligence combined with health care, using conditional random fields (CRF), recurrent neural network (RNN), convolutional neural network (CNN) and other deep learning algorithms, to solve the Natural Language Processing (NLP) of the named entity recognition, modification, text classification problems. To construct the medical knowledge map, combined with the related decision algorithm and model applied to clinical data center (CDR), electronic medical records system (EMR), clinical information system (CIS), health management system (PEIS), the clinical decision support (CDSS), medical record retrieval and analysis (CP), mining and application medical data (DATA MINING), Such innovative applications are leading the way across the country and even around the world.